Patent Portfolio
Our comprehensive patent portfolio is listed here for reference.
We maintain sublicenses for numerous iPS cell-related patents and patent applications, not limited to those from Kyoto University, but also from various other universities and research institutions.
Search
Search by tag
New
-
Differentiation
- Mesenchymal stem cells (MSC)
AJ314
Method for producing mesenchymal stem cells
The present invention relates to a method for producing mesenchymal stem cells, and more specifically to a method for producing mesenchymal stem cells using a medium composition containing a basal medium and an adrenocortical hormone.
- Pub. No.
- JP 2022-189188
- Pub. date
- 2022/12/22
-
Differentiation
- Heart (Myocardium)
AJ305
Method for producing mature cardiomyocytes
The present disclosure relates to methods for producing mature cardiomyocytes, methods for inducing the maturation of cardiomyocytes, etc.
- Pub. No.
- WO2026/048885
- Pub. date
- 2026/3/5
-
Drug Discovery / Therapy
- Nerve (Neuron)
AJ304
Maturation promoter for stem cell-derived non-mature nerve cells, maturation promotion method, proliferation inhibitor, and proliferation suppression method
The present invention relates to a maturation promoter, a maturation promoter method, a proliferation inhibitor, and a proliferation inhibitor method for immature nerve cells derived from stem cells.
- Pub. No.
- Pub. date
-
Drug Discovery / Therapy
- Heart (Myocardium)
AJ303
Cardiac function improving agent
This invention relates to a cardiac function improving agent. More specifically, it relates to a cardiac function improving agent including a fibroblast growth factor receptor (FGFR) inhibitor.
- Pub. No.
- WO2026/083624
- Pub. date
- 2026/4/23
-
Drug Discovery / Therapy
- Nerve (Neuron)
AJ302
Method for predicting prognosis of diseases caused by accumulation of abnormal protein
The present invention relates to a method for predicting the effectiveness of an oral medication in a subject against a disease caused by the accumulation of abnormal proteins. The present invention also relates to a method for assessing behavioral and psychological symptoms of dementia (BPSD).
- Pub. No.
- JP 2026-042645
- Pub. date
- 2026/3/11
-
Differentiation
- Heart (Myocardium)
AJ301
Mature cardiomyocyte production method
The present invention relates to a method for producing mature cardiomyocytes.
- Pub. No.
- WO2025/254117
- Pub. date
- 2025/12/11
-
Differentiation
- Pancreas
AJ300
Method for producing pancreatic beta cells
The present invention relates to a method for producing pancreatic beta cells, pancreatic beta cells produced by the method, and uses of the pancreatic beta cells.
- Pub. No.
- WO2026/004991
- Pub. date
- 2026/1/2
-
Others
AJ299
Nucleic acid aptamer, RNA molecule, pharmaceutical composition, and template DNA molecule
The present invention relates to nucleic acid aptamers that function as RNA sequences that enable cap-independent translation of mRNA, RNA molecules comprising the nucleic acid aptamers, pharmaceutical compositions containing the RNA molecules, and template DNA molecules.
- Pub. No.
- WO2025/249560
- Pub. date
- 2025/12/4
-
Drug Discovery / Therapy
- Nerve (Neuron)
AJ298
Prophylactic drug/therapeutic drug for progressive supranuclear palsy
The invention relates to a preventive and/or therapeutic agent for progressive supranuclear palsy (hereinafter, sometimes referred to as PSP). More specifically, it relates to a preventive and/or therapeutic agent for neurodegenerative diseases including PSP, which contains as an active ingredient a growth arrest and DNA damage-inducible protein 34 (hereinafter, sometimes referred to as GADD34; also known as protein phosphatase 1 regulatory subunit 15A; hereinafter, sometimes referred to as PPP1R15A, and GADD34 and PPP1R15A may be referred to together) inhibitor, such as guanabenz.
- Pub. No.
- WO2024/195858
- Pub. date
- 2024/9/26
-
Others
AJ297
Axioloid-based modular bottom-up in vitro model of human post-gastrulation development
The invention relates to a three-dimensional cellular aggregate termed axioloid generated in vitro from a pluripotent stem cell and to a method for producing the same.
- Pub. No.
- WO2025/070803
- Pub. date
- 2025/4/3
-
Others
AJ296
Target-molecule-specific functional protein control system
Theinvention relates to a target molecule-specific functional protein control system and method.
- Pub. No.
- WO2025/100390
- Pub. date
- 2025/5/15
-
Differentiation
- Mesenchymal stem cells (MSC)
AJ295
Method for producing neural crest cells
The invention relates to a method for producing neural crest cells. More specifically, it elates to a method for producing neural crest cells, which includes a step of performing suspension culture of pluripotent stem cells under specific conditions, and uses of neural crest cells obtained by the method.
- Pub. No.
- WO2024/242069
- Pub. date
- 2024/11/28
As for the patents and patent applications related to iPS cell technology, iPS Academia Japan, Inc. has been widely granted sublicensing rights not only from Kyoto University but also from several other universities and research institutions.
The number of patents and patent applications licensed to iPS Academia Japan, Inc. reached about 780 applications (about 200 families), of which about 520 applications have been issued as patents (in Japan, USA, Europe and other countries). (as of May 2022)
Please feel free to contact us if you are interested in such patent applications for licensing.
Our Licensors
- AIST
- KWANSEI GAKUIN UNIVERSITY
- NAGASAKI UNIVERSITY
- Accelerate Technologies Pte Ltd
- GIFU UNIVERSITY
- NAGOYA CITY UNIVERSITY
- Accellta Ltd.
- KYOTO UNIVERSITY
- NIHON UNIVERSITY
- JBiC
- KOBE UNIVERSITY
- YOKOHAMA CITY UNIVERSITY
- OSAKA UNIVERSITY
- CHIBA UNIVERSITY
- National Institutes for Quantum Science and Technology
- OKAYAMA UNIVERSITY
- TOKYO WOMEN'S MEDICAL UNIVERSITY
- ...etc